A prognosis-predictive nomogram of ovarian cancer with two immune
Evaluation of key genes and pathways in breast ductal carcinoma in situ
Breast most cancers (BC) stays the most common most cancers in females. Attributable to this truth, the present analysis aimed to determine key genes involved inside the carcinogenesis of BC and to find their prognostic values by integrating bioinformatics devices. The gene expression profiles of 46 ductal carcinoma in situ (DCIS) and three common breast tissues from the GSE59248 dataset have been downloaded. Differentially expressed genes (DEGs) have been subsequently acknowledged using the web machine GEO2R and a helpful enrichment analysis was carried out. In addition to, a protein-protein interaction (PPI) neighborhood was constructed and the best eight hub genes have been acknowledged.
The prognostic values of the hub genes have been further investigated. An entire of 316 DEGs, along with 32 upregulated and 284 downregulated genes, have been acknowledged. Furthermore, eight hub genes, along with lipase E hormone delicate type, patatin like phospholipase space containing 2, adiponectin C1Q and collagen space containing (ADIPOQ), peroxisome proliferator activated receptor γ (PPARG), fatty acid binding protein 4 (FABP4), diacylglycerol O-acyltransferase 2, lipoprotein lipase (LPL) and leptin (LEP), have been acknowledged from the PPI neighborhood.
The downregulated expression of ADIPOQ, PPARG, FABP4, LPL and LEP was significantly associated to poor whole survival in victims with DCIS. Attributable to this truth, these genes may operate potential biomarkers for prognosis prediction. Nonetheless, further investigation is required to validate the outcomes obtained inside the present analysis.
Trametinib |
|||
T2125-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
T2125-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trametinib |
Trametinib |
|||
abx283095-100g | Abbexa | 100 µg | Ask for price |
Trametinib |
|||
abx283095-20g | Abbexa | 20 µg | EUR 106.25 |
Trametinib |
|||
abx283095-50g | Abbexa | 50 µg | EUR 237.5 |
Trametinib |
|||
MBS3606330-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib |
|||
MBS3606330-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib |
|||
MBS3606330-200mg | MyBiosource | 200mg | EUR 275 |
Trametinib |
|||
MBS3606330-50mg | MyBiosource | 50mg | EUR 215 |
Trametinib |
|||
MBS3606330-5x200mg | MyBiosource | 5x200mg | EUR 920 |
Trametinib-13C6 |
|||
C988931 | Toronto Research Chemicals | 0.5mg | EUR 4669 |
Trametinib-13C6 |
|||
HY-10999S1 | MedChemExpress | 1mg | Ask for price |
Description: Trametinib-13C6 is the 13C-labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Ripa lysate (strong) |
|||
E1WP106 | EnoGene | 50ML | EUR 60 |
Trametinib-13C,d3 |
|||
HY-10999S2 | MedChemExpress | 1mg | EUR 1007.59 |
Description: Trametinib-13C,d3 is the 13C- and deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Trametinib-d4 |
|||
T712602 | Toronto Research Chemicals | 100mg | EUR 4500 |
Trametinib-d4 |
|||
HY-10999S | MedChemExpress | 1mg | Ask for price |
Description: Trametinib-d4 is the deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2]. |
Deiodo Trametinib |
|||
D397050 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 871700-65-1 |
Trametinib (GSK1120212) |
|||
A3018-200 | ApexBio | 200 mg | EUR 154 |
Description: MEK1 and MEK2 inhibitor, potent and selective |
Trametinib (GSK1120212) |
|||
A3018-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: MEK1 and MEK2 inhibitor, potent and selective |
Trametinib (GSK1120212) |
|||
A3018-50 | ApexBio | 50 mg | EUR 77 |
Description: MEK1 and MEK2 inhibitor, potent and selective |
Trametinib (GSK1120212) |
|||
A3018-500 | ApexBio | 500 mg | EUR 324 |
Description: MEK1 and MEK2 inhibitor, potent and selective |
Trametinib (GSK1120212) |
|||
A3018-S | ApexBio | Evaluation Sample | EUR 22 |
Description: MEK1 and MEK2 inhibitor, potent and selective |
Trametinib (GSK1120212) |
|||
MBS576333-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib (GSK1120212) |
|||
MBS576333-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib (GSK1120212) |
|||
MBS576333-200mg | MyBiosource | 200mg | EUR 210 |
Trametinib (GSK1120212) |
|||
MBS576333-50mg | MyBiosource | 50mg | EUR 155 |
Trametinib (GSK1120212) |
|||
MBS576333-5mg | MyBiosource | 5mg | EUR 130 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100ml | Abbexa | 100 ml | EUR 260.4 |
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-100mL | Elabscience Biotech | 100mL | EUR 80 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-20mL | Elabscience Biotech | 20mL | EUR 25 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-50mL | Elabscience Biotech | 50mL | EUR 60 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-each | Elabscience Biotech | each | Ask for price |
Strong RIPA Lysis Buffer |
|||
EZPS03-1 | Shanghai WSHT Biotechnology | 100mL | EUR 15 |
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-100mL | MyBiosource | 100mL | EUR 210 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-5x100mL | MyBiosource | 5x100mL | EUR 640 |
Trametinib DMSO solvate |
|||
123211 | MedKoo Biosciences | 10.0mg | EUR 90 |
Trametinib DMSO solvate |
|||
A3887-10 | ApexBio | 10 mg | EUR 40 |
Description: Allosteric MEK1/MEK2 kinase inhibitor |
Trametinib DMSO solvate |
|||
A3887-100 | ApexBio | 100 mg | EUR 95 |
Description: Allosteric MEK1/MEK2 kinase inhibitor |
Trametinib DMSO solvate |
|||
A3887-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Allosteric MEK1/MEK2 kinase inhibitor |
Trametinib DMSO solvate |
|||
A3887-50 | ApexBio | 50 mg | EUR 64 |
Description: Allosteric MEK1/MEK2 kinase inhibitor |
Trametinib (DMSO solvate) |
|||
HY-10999A | MedChemExpress | 100mg | EUR 256.8 |
Trametinib Impurity-I |
|||
T138340 | Toronto Research Chemicals | 10mg | EUR 800 |
Description: 1383430-03-2 |
Trametinib (DMSO Solvate) |
|||
T314310 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 1187431-43-1 |
Trametinib (DMSO solvate) |
|||
T5857-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
T5857-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Trametinib (DMSO solvate) |
Trametinib (DMSO solvate) |
|||
MBS3845880-100mg | MyBiosource | 100mg | EUR 425 |
Trametinib (DMSO solvate) |
|||
MBS3845880-10mg | MyBiosource | 10mg | EUR 140 |
Trametinib (DMSO solvate) |
|||
MBS3845880-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib (DMSO solvate) |
|||
MBS3845880-50mg | MyBiosource | 50mg | EUR 275 |
Trametinib (DMSO solvate) |
|||
MBS3845880-5x100mg | MyBiosource | 5x100mg | EUR 1910 |
Trametinib DMSO solvate |
|||
MBS3600640-100mg | MyBiosource | 100mg | EUR 245 |
Trametinib DMSO solvate |
|||
MBS3600640-10mg | MyBiosource | 10mg | EUR 200 |
Trametinib DMSO solvate |
|||
MBS3600640-200mg | MyBiosource | 200mg | EUR 290 |
Trametinib DMSO solvate |
|||
MBS3600640-25mg | MyBiosource | 25mg | EUR 200 |
Trametinib DMSO solvate |
|||
MBS3600640-50mg | MyBiosource | 50mg | EUR 220 |
Trametinib DMSO solvate |
|||
MBS5752199-100mg | MyBiosource | 100mg | EUR 180 |
Trametinib DMSO solvate |
|||
MBS5752199-10mg | MyBiosource | 10mg | EUR 145 |
Trametinib DMSO solvate |
|||
MBS5752199-200mg | MyBiosource | 200mg | EUR 225 |
Trametinib DMSO solvate |
|||
MBS5752199-25mg | MyBiosource | 25mg | EUR 145 |
Trametinib DMSO solvate |
|||
MBS5752199-50mg | MyBiosource | 50mg | EUR 160 |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
OOMC00081-10MG - Trametinib |
|||
OOMC00081-10MG | Aviva Systems Biology | 10mg | EUR 59 |
OOMC00081-50MG - Trametinib |
|||
OOMC00081-50MG | Aviva Systems Biology | 50mg | EUR 199 |
Trametinib [CAS# 871700-17-3] |
|||
T-8123 | LC LABORATORIES | 10 mg | EUR 38 |
Trametinib dimethyl sulfoxide |
|||
414033 | MedKoo Biosciences | 25.0mg | EUR 228 |
Clear Seal Strong Sheet (100) |
|||
MAAB-0685 | Westburg | each | EUR 255.61 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-100mg | MyBiosource | 100mg | EUR 210 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-10mg | MyBiosource | 10mg | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 145 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-50mg | MyBiosource | 50mg | EUR 170 |
GSK1120212 (JTP-74057, Trametinib) |
|||
MBS384815-5mg | MyBiosource | 5mg | EUR 130 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
Tissue/cell lysis buffer(Strong) |
|||
RM17482 | Abclonal | 10mL | EUR 53.14 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
Trametinib, DMSO Solvate [CAS# 1187431-43-1] |
|||
T-8188 | LC LABORATORIES | 10 mg | EUR 38 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
anti PAI-1 (very strong for human) |
|||
MBS480230-1mg | MyBiosource | 1mg | EUR 790 |
anti PAI-1 (very strong for human) |
|||
MBS480230-5x1mg | MyBiosource | 5x1mg | EUR 3315 |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 48 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 431 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 113 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
Seralite SRC-120, Strong Acid Cation Exchange Resin |
|||
14891 | Sisco Laboratories | 500 Gms | EUR 3.76 |
Description: Part A |
Seralite SRA-400, Strong Basic Anion Exchange Resin |
|||
52228 | Sisco Laboratories | 500 Gms | EUR 5.82 |
Description: Part A |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 192 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 62 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 1150 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 69011-15-0 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 9052-45-3 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 850 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 850 |
A prognosis-predictive nomogram of ovarian most cancers with two immune-related genes: CDC20B and PNPLA5
Ovarian carcinoma (OV) is probably going one of the lethal gynecological malignancies globally, and the final 5-year survival cost of OV was 47% in 2018 based mostly on American info. To increase the survival cost of victims with OV, many researchers have sought to determine biomarkers that act as every prognosis-predictive markers and treatment targets.
Nonetheless, most of these have not been acceptable for scientific software program. The present analysis geared towards establishing a predictive prognostic nomogram of OV using the genes acknowledged by combining The Most cancers Genome Atlas (TCGA) dataset for OV with the immune score calculated by the Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression info algorithm. Firstly, the algorithm was used to calculate the immune score of victims with OV inside the TCGA-OV dataset.
Secondly, differentially expressed genes (DEGs) between excessive and low immune score tissues have been acknowledged, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis was carried out to predict the options of these DEGs. Thirdly, univariate, multivariate and Lasso Cox’s regression analyses have been carried out step-by-step, and 6 prognosis-relatedDEGs have been acknowledged.
Then, Kaplan-Myer survival curves have been generated for these genes and validated by evaluating their expression ranges to further slender the fluctuate of DEGs and to calculate the hazard score. Two genes have been acknowledged, cell division cycle 20B and patatin-like phospholipase space containing 5, which have been every confirmed to have elevated expression ranges in OV tissues and to be significantly associated to the prognosis of OV.
Subsequent, a nomogram was created using these two genes and age, and using the receiver working attribute (ROC) curve and calibration curve, the effectiveness of the nomogram was validated. Lastly, an exterior validation was carried out for this nomogram. The ROC confirmed that the areas beneath the curve (AUCs) of the 3- and 5-year whole survival predictions for the nomogram have been 0.678 and 0.62, respectively. Moreover, the ROC of the outside validation model confirmed that the AUCs of the 3- and 5-year have been 0.699 and 0.643, respectively, demonstrating the effectiveness of the generated nomogram. In conclusion, the present analysis has acknowledged two immune-related genes as biomarkers that reliably predict whole survival in OV. These biomarkers can also be potential molecular targets of immune treatment to cope with victims with OV.
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-100mL | MyBiosource | 100mL | EUR 210 |
RIPA Lysis Buffer (Strong) |
|||
MBS355478-5x100mL | MyBiosource | 5x100mL | EUR 640 |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
Clear Seal Strong Sheet (100) |
|||
MAAB-0685 | Westburg | each | EUR 255.61 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
Tissue/cell lysis buffer(Strong) |
|||
RM17482 | Abclonal | 10mL | EUR 53.14 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
anti PAI-1 (very strong for human) |
|||
MBS480230-1mg | MyBiosource | 1mg | EUR 790 |
anti PAI-1 (very strong for human) |
|||
MBS480230-5x1mg | MyBiosource | 5x1mg | EUR 3315 |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 48 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 431 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 113 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
Seralite SRC-120, Strong Acid Cation Exchange Resin |
|||
14891 | Sisco Laboratories | 500 Gms | EUR 3.76 |
Description: Part A |
Seralite SRA-400, Strong Basic Anion Exchange Resin |
|||
52228 | Sisco Laboratories | 500 Gms | EUR 5.82 |
Description: Part A |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 192 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 62 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 1150 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 69011-15-0 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 9052-45-3 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 850 |
Rapamycin |
|||
20-abx076788 | Abbexa |
|
|
Rapamycin |
|||
1568-5 | Biovision | each | EUR 339.6 |
Rapamycin |
|||
1568-50 | Biovision | each | EUR 1396.8 |
Rapamycin |
|||
30037-94 | NACALAI TESQUE | 100UG | EUR 138.6 |
Rapamycin |
|||
27062 | BPS Bioscience | 50 mg | EUR 135 |
Description: Immunosuppressant, related to FK-506, but without calcineurin inhibitory activity even when complexed to FK-506 binding protein. Selectively blocks signaling that leads to p70 S6 kinase activation (IC50 = 50 pM). |
Rapamycin |
|||
41810000-1 | Glycomatrix | 10 mg | EUR 52.16 |
Rapamycin |
|||
41810000-2 | Glycomatrix | 100 mg | EUR 161.05 |
Rapamycin |
|||
41810000-3 | Glycomatrix | 50 mg | EUR 89.68 |
Rapamycin |
|||
41810000-4 | Glycomatrix | 500 mg | EUR 364.2 |
Rapamycin |
|||
20-abx185560 | Abbexa |
|
|
Rapamycin |
|||
E1B1842 | EnoGene | 1mg | EUR 60 |
Rapamycin |
|||
tlrl-rap-5 | InvivoGen FR | 5 x 5 mg | EUR 248.85 |
Rapamycin |
|||
GA7417 | Glentham Life Sciences | 5mg | EUR 181.03 |
Rapamycin |
|||
G613 | ABM | 100 mg | EUR 800 |
Rapamycin |
|||
MBS132175-100mg | MyBiosource | 100mg | EUR 1065 |
Rapamycin |
|||
MBS132175-500mg | MyBiosource | 500mg | EUR 2775 |
Rapamycin |
|||
HY-10219 | MedChemExpress | 200mg | EUR 241.2 |
Rapamycin |
|||
GA7417-100 | Glentham Life Sciences | 100 | EUR 197.7 |
Rapamycin |
|||
GA7417-100MG | Glentham Life Sciences | 100 mg | EUR 274.8 |
Rapamycin |
|||
GA7417-25 | Glentham Life Sciences | 25 | EUR 63.3 |
Rapamycin |
|||
GA7417-25MG | Glentham Life Sciences | 25 mg | EUR 112.8 |
Rapamycin |
|||
GA7417-5 | Glentham Life Sciences | 5 | EUR 23.8 |
Rapamycin |
|||
GA7417-50 | Glentham Life Sciences | 50 | EUR 118.7 |
Rapamycin |
|||
GA7417-50MG | Glentham Life Sciences | 50 mg | EUR 180 |
Rapamycin |
|||
GA7417-5MG | Glentham Life Sciences | 5 mg | EUR 64.8 |
Rapamycin |
|||
R001-10MG | TOKU-E | 10 mg | EUR 149.37 |
Description: C51H79NO13 |
Rapamycin |
|||
R001-25MG | TOKU-E | 25 mg | EUR 187.13 |
Description: C51H79NO13 |
Rapamycin |
|||
SIH-212-25MG | Stressmarq | 25 mg | EUR 345 |
Description: mTOR inhibitor |
Rapamycin |
|||
SIH-212-5MG | Stressmarq | 5 mg | EUR 138 |
Description: mTOR inhibitor |
Rapamycin |
|||
T1537-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
T1537-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Rapamycin |
Rapamycin |
|||
abx076788-100l | Abbexa | 100 µl | EUR 118.75 |
Rapamycin |
|||
abx076788-1ml | Abbexa | 1 ml | Ask for price |
Rapamycin |
|||
abx076788-200l | Abbexa | 200 µl | EUR 300 |
Rapamycin |
|||
MBS696245-10mg | MyBiosource | 10mg | EUR 235 |
Rapamycin |
|||
MBS696245-1mg | MyBiosource | 1mg | EUR 135 |
Rapamycin |
|||
MBS696245-5x10mg | MyBiosource | 5x10mg | EUR 1005 |
Rapamycin |
|||
MBS807957-25mg | MyBiosource | 25mg | EUR 450 |
Rapamycin |
|||
MBS807957-5mg | MyBiosource | 5mg | EUR 260 |
Rapamycin |
|||
MBS807957-5x25mg | MyBiosource | 5x25mg | EUR 1770 |
Rapamycin |
|||
MBS807957-5x5mg | MyBiosource | 5x5mg | EUR 905 |
Rapamycin |
|||
MBS8579821-1mg | MyBiosource | 1mg | EUR 155 |
Rapamycin |
|||
MBS8579821-5x1mg | MyBiosource | 5x1mg | EUR 555 |
Rapamycin |
|||
MBS407517-100mg | MyBiosource | 100mg | EUR 175 |
Rapamycin |
|||
MBS407517-1g | MyBiosource | 1g | EUR 450 |
Rapamycin |
|||
MBS407517-5x100mg | MyBiosource | 5x100mg | EUR 730 |
Rapamycin |
|||
MBS407517-5x1g | MyBiosource | 5x1g | EUR 1970 |
Rapamycin |
|||
MBS3604884-100mg | MyBiosource | 100mg | EUR 210 |
Rapamycin |
|||
MBS3604884-200mg | MyBiosource | 200mg | EUR 240 |
Rapamycin |
|||
MBS3604884-50mg | MyBiosource | 50mg | EUR 195 |
Rapamycin |
|||
MBS3604884-5x200mg | MyBiosource | 5x200mg | EUR 760 |
Rapamycin |
|||
MBS515013-100mg | MyBiosource | 100mg | EUR 665 |
Rapamycin |
|||
MBS515013-20mg | MyBiosource | 20mg | EUR 320 |
Rapamycin |
|||
MBS515013-5x100mg | MyBiosource | 5x100mg | EUR 2740 |
Rapamycin, 100mg |
|||
R5312 | ACTGene | 100mg | EUR 607.18 |
Rapamycin, 100mg |
|||
R5312-100mg | ACTGene | each | EUR 902.4 |
Rapamycin, >99% |
|||
BC082-050 | GenDepot | 50mg | EUR 262.8 |
Rapamycin, >99% |
|||
BC082-100 | GenDepot | 100mg | EUR 313.2 |
Rapamycin, >99% |
|||
BC082-250 | GenDepot | 250mg | EUR 424.8 |
Rapamycin, >99% |
|||
BC082-500 | GenDepot | 500mg | EUR 651.6 |
Rapamycin (>85%) |
|||
R124000 | Toronto Research Chemicals | 100mg | EUR 80 |
Description: 53123-88-9 |
Rapamycin (GMP) |
|||
HY-10219G | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin (Sirolimus) (GMP) is Rapamycin (HY-10219) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Rapamycin is a potent and specific mTOR inhibitor[1][2][3]. |
Rapamycin-13C,d3 |
|||
HY-10219S1 | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin-13C,d3 (Sirolimus-13C,d3; AY-22989-13C,d3) is the 13C and deuterium labeled Rapamycin (HY-10219)[1]. Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[2]. Rapamycin is an autophagy activator, an immunosuppressant[3]. |
Seco Rapamycin |
|||
HY-19555 | MedChemExpress | 50mg | EUR 2704.8 |
Rapamycin, 10mg |
|||
R5312-10mg | ACTGene | each | EUR 244.8 |
Rapamycin-d3 |
|||
T12691-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Rapamycin-d3 |
Rapamycin-d3 |
|||
T12691-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Rapamycin-d3 |
Seco Rapamycin |
|||
T38963-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
T38963-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Seco Rapamycin |
Seco Rapamycin |
|||
MBS5799522-5mg | MyBiosource | 5(mg | EUR 915 |
Seco Rapamycin |
|||
MBS5799522-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Rapamycin-d3 |
|||
HY-10219S | MedChemExpress | 1 mg | EUR 119.05 |
Description: Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific mTOR inhibitor with an IC50of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2]. |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 850 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity |
|||
DAG-YS23-29 | Creative Diagnostics | 25 mL | EUR 850 |
Sirolimus (Rapamycin) |
|||
100766 | MedKoo Biosciences | 25.0mg | EUR 90 |
Rapamycin (Sirolimus) |
|||
E1KS1039 | EnoGene | 50mg | EUR 120 |
Rapamycin (Sirolimus) |
|||
A8167-100 | ApexBio | 100 mg | EUR 154 |
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
|||
A8167-25 | ApexBio | 25 mg | EUR 74 |
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
|||
A8167-5 | ApexBio | 5 mg | EUR 33 |
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
|||
A8167-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 48 |
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
|||
A8167-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Original antifungal antibiotic |
Rapamycin (Sirolimus) |
|||
MBS8506576-50mg | MyBiosource | 50mg | EUR 210 |
Rapamycin (Sirolimus) |
|||
MBS8506576-5x50mg | MyBiosource | 5x50mg | EUR 800 |
Rapamycin (Sirolimus) |
|||
MBS386035-100mg | MyBiosource | 100mg | EUR 160 |
Rapamycin (Sirolimus) |
|||
MBS386035-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 140 |
Rapamycin (Sirolimus) |
|||
MBS386035-50mg | MyBiosource | 50mg | EUR 145 |
Rapamycin (Sirolimus) |
|||
MBS386035-5mg | MyBiosource | 5mg | EUR 130 |
Rapamycin (Sirolimus) |
|||
MBS386035-5x100mg | MyBiosource | 5x100mg | EUR 715 |
Rapamycin (Sirolimus) |
|||
MBS575148-100mg | MyBiosource | 100mg | EUR 155 |
Rapamycin (Sirolimus) |
|||
MBS575148-200mg | MyBiosource | 200mg | EUR 185 |
Rapamycin (Sirolimus) |
|||
MBS575148-25mg | MyBiosource | 25mg | EUR 135 |
Rapamycin (Sirolimus) |
|||
MBS575148-500mg | MyBiosource | 500mg | EUR 260 |
Rapamycin (Sirolimus) |
|||
MBS575148-50mg | MyBiosource | 50mg | EUR 145 |
Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk |
|||
MS1000-F2 | Benchmark Scientific | 1 each | EUR 149.35 |
EZSolution? Rapamycin |
|||
1746-5 | Biovision | each | EUR 326.4 |
Estrogen receptor (ER) IHC control with strong, moderate, low/negative expressersHumanBreastBreastIHC control |
|||
ERC083 | Pantomics | 1.5mm | EUR 50 |
Rapamycin analog-2 |
|||
HY-153511 | MedChemExpress | Get quote | Ask for price |
Description: Rapamycin analog-2 (compound A) is a Rapamycin analog[1]. |
rapamycin derivative 1 |
|||
R454500 | Toronto Research Chemicals | 25mg | EUR 1800 |
rapamycin derivative 2 |
|||
R574880 | Toronto Research Chemicals | 100mg | EUR 9200 |
TOR | Target of rapamycin |
|||
AS12-2608 | Agrisera AB | 50 µg | EUR 302 |
OOMC00007-10MG - Rapamycin |
|||
OOMC00007-10MG | Aviva Systems Biology | 10mg | EUR 69 |
OOMC00007-50MG - Rapamycin |
|||
OOMC00007-50MG | Aviva Systems Biology | 50mg | EUR 249 |
Rapamycin-31,42-Diester Impurity |
|||
R124015 | Toronto Research Chemicals | 50mg | EUR 1938 |
Rapamycin [CAS# 53123-88-9] |
|||
R-5000 | LC LABORATORIES | 50 mg | EUR 48 |
33-O-Formyl Rapamycin |
|||
F699010 | Toronto Research Chemicals | 10mg | EUR 1728 |
Seco Rapamycin (sodium salt) |
|||
HY-19555A | MedChemExpress | 1mg | EUR 207.6 |
7-O-Demethyl rapamycin |
|||
T25882-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
7-O-Demethyl rapamycin |
|||
T25882-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 7-O-Demethyl rapamycin |
Seco Rapamycin sodium salt |
|||
T19558-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Seco Rapamycin sodium salt |
Seco Rapamycin sodium salt |
|||
T19558-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Seco Rapamycin sodium salt |
7-O-Demethyl Rapamycin |
|||
MBS6080732-25mg | MyBiosource | 2.5(mg | EUR 665 |
7-O-Demethyl Rapamycin |
|||
MBS6080732-5x25mg | MyBiosource | 5x2.5mg | EUR 2845 |
7-O-Demethyl rapamycin |
|||
MBS5775613-10mg | MyBiosource | 10mg | EUR 2020 |
7-O-Demethyl rapamycin |
|||
MBS5775613-25mg | MyBiosource | 25mg | EUR 1995 |
7-O-Demethyl rapamycin |
|||
MBS5775613-5mg | MyBiosource | 5(mg | EUR 1235 |
Seco Rapamycin sodium salt |
|||
MBS3602049-10mg | MyBiosource | 10mg | EUR 655 |
Seco Rapamycin sodium salt |
|||
MBS3602049-25mg | MyBiosource | 25mg | EUR 1075 |
Seco Rapamycin sodium salt |
|||
MBS3602049-50mg | MyBiosource | 50mg | EUR 1630 |
Seco Rapamycin sodium salt |
|||
MBS3602049-5mg | MyBiosource | 5mg | EUR 465 |
Seco Rapamycin sodium salt |
|||
MBS3602049-5x50mg | MyBiosource | 5x50mg | EUR 7015 |
Seco Rapamycin sodium salt |
|||
MBS5756112-25mg | MyBiosource | 25mg | EUR 1405 |
Seco Rapamycin sodium salt |
|||
MBS5756112-50mg | MyBiosource | 50mg | EUR 2410 |
Seco Rapamycin sodium salt |
|||
MBS5756112-5x50mg | MyBiosource | 5x50mg | EUR 10695 |
7-O-Demethyl rapamycin |
|||
HY-123691 | MedChemExpress | Get quote | Ask for price |
Description: 7-O-Demethyl rapamycin, a derivative of Rapamycin (HY-10219), has antifungal activity and immunosuppressant properties. 7-O-Demethyl rapamycin has useful tumor cell growth-inhibiting activity[1]. |
Seco Rapamycin ethyl ester |
|||
HY-133770 | MedChemExpress | 10 mg | EUR 2380.99 |
Description: Seco Rapamycin ethyl ester is an open-ring metabolite of Rapamycin derivative. Seco-rapamycin is reported not to affect the mTOR function[1]. |
42-(2-Tetrazolyl)rapamycin |
|||
HY-12424A | MedChemExpress | 1mg | EUR 241.2 |
42-(2-Tetrazolyl)rapamycin |
|||
T10158-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
|||
T10158-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
|||
T10158-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
|||
T10158-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 42-(2-Tetrazolyl)rapamycin |
42-(2-Tetrazolyl)rapamycin |
|||
T10158-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 42-(2-Tetrazolyl)rapamycin |